Tower Research Capital LLC (Trc) Ovid Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,301 shares of OVID stock, worth $7,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,301
Previous 14,177
41.45%
Holding current value
$7,885
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding OVID
# of Institutions
75Shares Held
39MCall Options Held
37.4KPut Options Held
500-
Rubric Capital Management LP New York, NY5.32MShares$5.05 Million0.17% of portfolio
-
Madison Avenue Partners, LP New York, NY4.12MShares$3.91 Million0.6% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$3.79 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$3.66 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$2.99 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $66.9M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...